Koebner Phenomenon: Café-au-Lait Spots Developing after a Secondary-Degree Burn in a Patient with Neurofibromatosis Type 1.

Autor: Feily A; Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran., Niaz MJ; Department of Urology, Weill Cornell Medicine, New York, NY., Fort M; Department of Life Sciences, BioFort Corp., Guaynabo, Puerto Rico., Morales-Cruz M; Department of Basic Sciences, School of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico., Niaz MO; Department of Medicine, Sharif Medical City Hospital, Lahore, Pakistan., Lange CS; Department of Life Sciences, BioFort Corp., Guaynabo, Puerto Rico.; Department of Radiation Oncology, SUNY Downstate Health Sciences University, Brooklyn, NY., Ramirez-Fort MK; Department of Urology, Weill Cornell Medicine, New York, NY.; Department of Life Sciences, BioFort Corp., Guaynabo, Puerto Rico.; Department of Radiation Oncology, SUNY Downstate Health Sciences University, Brooklyn, NY; marigdalia@biofort.io.

Publikováno v: Skinmed [Skinmed] 2022 Feb 28; Vol. 20 (1), pp. 72-74. Date of Electronic Publication: 2022 Feb 28 (Print Publication: 2022).

Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted β-emitting radionuclide therapies in metastatic castration-resistant prostate cancer.

Autor: Vlachostergios PJ; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, USA., Niaz MJ; Department of Urology, Weill Cornell Medicine, New York, USA., Skafida M; Department of Radiology, Division of Molecular Imaging and Therapeutics, Weill Cornell Medicine, New York, USA., Mosallaie SA; Department of Radiology, Division of Molecular Imaging and Therapeutics, Weill Cornell Medicine, New York, USA., Thomas C; Department of Healthcare Policy & Research, Division of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, USA., Christos PJ; Department of Healthcare Policy & Research, Division of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, USA., Osborne JR; Department of Radiology, Division of Molecular Imaging and Therapeutics, Weill Cornell Medicine, New York, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, USA., Molina AM; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, USA., Nanus DM; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, USA.; Department of Urology, Weill Cornell Medicine, New York, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, USA., Bander NH; Department of Urology, Weill Cornell Medicine, New York, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, USA., Tagawa ST; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, USA.; Department of Urology, Weill Cornell Medicine, New York, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, USA.

Publikováno v: The Prostate [Prostate] 2021 Apr; Vol. 81 (5), pp. 279-285. Date of Electronic Publication: 2021 Jan 19.

Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinoma.

Autor: Ramirez-Fort MK; Department of Life Sciences, BioFort®, Guaynabo, Puerto Rico, USA.; Department of Urology, Weill Cornell Medicine, New York, New York, USA.; Department of Radiation Oncology, SUNY Downstate Health Sciences University, Brooklyn, New York, USA., Meier-Schiesser B; Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland., Lachance K; Department of Dermatology, University of Washington, Seattle, Washington, USA., Mahase SS; Department of Radiation Oncology, Weill Cornell Medicine, New York, New York, USA., Church CD; Department of Dermatology, University of Washington, Seattle, Washington, USA., Niaz MJ; Department of Urology, Weill Cornell Medicine, New York, New York, USA., Liu H; Department of Urology, Weill Cornell Medicine, New York, New York, USA., Navarro V; Department of Urology, Weill Cornell Medicine, New York, New York, USA., Nikolopoulou A; Department of Radiology, Weill Cornell Medicine, New York, New York, USA., Kazakov DV; Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.; Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic., Contassot E; Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland., Nguyen DP; Department of Urology, Weill Cornell Medicine, New York, New York, USA., Sach J; Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic., Hadravsky L; Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic., Sheng Y; Shanghai Proton and Heavy Ion Center, Shanghai, China., Tagawa ST; Department of Urology, Weill Cornell Medicine, New York, New York, USA.; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Wu X; Shanghai Proton and Heavy Ion Center, Shanghai, China.; Innovative Cancer Institute, Miami, Florida, USA., Lange CS; Department of Life Sciences, BioFort®, Guaynabo, Puerto Rico, USA.; Department of Radiation Oncology, SUNY Downstate Health Sciences University, Brooklyn, New York, USA., French LE; Department of Dermatology, Münich University Hospital, Münich, Germany., Nghiem PT; Department of Dermatology, University of Washington, Seattle, Washington, USA., Bander NH; Department of Urology, Weill Cornell Medicine, New York, New York, USA.

Publikováno v: Skin health and disease [Skin Health Dis] 2021 Mar; Vol. 1 (1). Date of Electronic Publication: 2020 Nov 28.

Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( ¹⁷⁷ Lu-J591) for metastatic castration-resistant prostate cancer.

Autor: Batra JS; Department of Urology, Weill Cornell Medicine, New York, NY., Niaz MJ; Department of Urology, Weill Cornell Medicine, New York, NY., Whang YE; Department of Medicine, Division of Hematology/Oncology, University of North Carolina School of Medicine, Chapel Hill, NC., Sheikh A; Department of Radiology, Icahn School of Medciine at Mount Sinai, New York, NY., Thomas C; Department of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY., Christos P; Department of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY., Vallabhajosula S; Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, NY., Jhanwar YS; Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, NY., Molina AM; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY., Nanus DM; Department of Urology, Weill Cornell Medicine, New York, NY; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY., Osborne JR; Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY., Bander NH; Department of Urology, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY., Tagawa ST; Department of Urology, Weill Cornell Medicine, New York, NY; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY. Electronic address: stt2007@med.cornell.edu.

Publikováno v: Urologic oncology [Urol Oncol] 2020 Nov; Vol. 38 (11), pp. 848.e9-848.e16. Date of Electronic Publication: 2020 Jun 27.

Pseudo-dense Hair Transplantation: Strategy of "Less Inside, More Outside" and Central Bulking with Curled Chest Hairs as Treatment for Scalp Scars.

Autor: Feily A; Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran., Feily A; Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran., Alexander JS; Department of Physiology/Pathology, San Juan Bautista School of Medicine, Caguas, Puerto Rico, USA., Niaz MJ; Department of Urology, Weill Cornell Medicine, New York, New York, USA., Gianfaldoni S; Department of Dermatology, Guglielmo Marconi University, Rome, Italy., Lotti T; Department of Dermatology, Guglielmo Marconi University, Rome, Italy., Ramirez-Fort MK; Department of Physiology/Pathology, San Juan Bautista School of Medicine, Caguas, Puerto Rico, USA.; Department of Urology, Weill Cornell Medicine, New York, New York, USA.; Department of Life Sciences, BioFort Corp., Guaynabo, Puerto Rico, USA.

Publikováno v: Journal of cutaneous and aesthetic surgery [J Cutan Aesthet Surg] 2020 Jul-Sep; Vol. 13 (3), pp. 226-228.